These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 8309995
1. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM. Pharmacol Ther; 1993 Sep; 59(3):329-41. PubMed ID: 8309995 [Abstract] [Full Text] [Related]
2. Structure-function relationships in the tissue inhibitors of metalloproteinases. Willenbrock F, Murphy G. Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S165-70. PubMed ID: 7952654 [Abstract] [Full Text] [Related]
3. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Ward RV, Hembry RM, Reynolds JJ, Murphy G. Biochem J; 1991 Aug 15; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113 [Abstract] [Full Text] [Related]
5. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL. Ann Rheum Dis; 1995 Jan 15; 54(1):25-32. PubMed ID: 7880117 [Abstract] [Full Text] [Related]
12. Degradation of matrix proteins in liver fibrosis. Arthur MJ. Pathol Res Pract; 1994 Oct 15; 190(9-10):825-33. PubMed ID: 7899131 [Abstract] [Full Text] [Related]
13. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC. Biochem J; 1996 Apr 01; 315 ( Pt 1)(Pt 1):335-42. PubMed ID: 8670128 [Abstract] [Full Text] [Related]
15. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Oliver GW, Leferson JD, Stetler-Stevenson WG, Kleiner DE. Anal Biochem; 1997 Jan 01; 244(1):161-6. PubMed ID: 9025922 [Abstract] [Full Text] [Related]
16. The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproduction. Khokha R, Waterhouse P. J Neurooncol; 1994 Jan 01; 18(2):123-7. PubMed ID: 7525887 [Abstract] [Full Text] [Related]
17. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL. J Cell Physiol; 1993 Aug 01; 156(2):235-46. PubMed ID: 8344982 [Abstract] [Full Text] [Related]
18. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. Khokha R. J Natl Cancer Inst; 1994 Feb 16; 86(4):299-304. PubMed ID: 8158685 [Abstract] [Full Text] [Related]
19. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Chesler L, Golde DW, Bersch N, Johnson MD. Blood; 1995 Dec 15; 86(12):4506-15. PubMed ID: 8541540 [Abstract] [Full Text] [Related]
20. A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts. Moore WG, Birkedal-Hansen B, Pierson M, Birkedal-Hansen H. Matrix Suppl; 1992 Dec 15; 1():319-20. PubMed ID: 1480050 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]